Age at revision cochlear implantation does not impact post-revision speech perception performance.
Akorn announced it has received approval from the Food and Drug Administration (FDA) on its New Drug Application (NDA) for Phenylephrine HCl Ophthalmic Solution.
Increased odds of musculoskeletal injury, fracture, fall for older Medicare beneficiaries
Featured courses from mycme
Blurred vision - Red flag symptoms
This module reviews all topics on the NCCPA examination blueprint relating to Pulmonology, Ophthalmology, and ...
This webcast will discuss the pathophysiology and diagnostic criteria of VMA/VMT and treatment options for ...